The increase in Col3a1 expression and changes in collagen-I:collagen-III ratio alter the collagen-I microstructure [66] and are implicated in the production of therapeutic resistance to corticosteroids in pulmonary fibrosis [67]. This evidence concerns the gene COL3A1 and pulmonary fibrosis.